Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-08-04 5:11 pm Purchase | 2021-08-02 | 13D | Nuvalent, Inc. NUVL | Bain Capital Life Sciences Fund II, L.P. | 2,400,630 5.600% | 2,400,630 (New Position) | Filing History |
| 2021-03-17 4:15 pm Purchase | 2021-03-15 | 13D | Savara Inc. SVRA | Bain Capital Life Sciences Fund II, L.P. | 11,622,598 13.000% | 6,494,005 (+126.62%) | Filing History |
| 2021-01-12 5:19 pm Purchase | 2021-01-08 | 13D | Mersana Therapeutics, Inc. MRSN | Bain Capital Life Sciences Fund II, L.P. | 3,294,423 4.800% | 222,857 (+7.26%) | Filing History |
| 2020-12-14 5:12 pm Purchase | 2020-12-08 | 13G | Syros Pharmaceuticals, Inc. SYRS | Bain Capital Life Sciences Fund II, L.P. | 578,504 11.000% | 578,504 (New Position) | Filing History |
| 2020-11-12 4:15 pm Purchase | 2020-11-03 | 13D | Atea Pharmaceuticals, Inc. AVIR | Bain Capital Life Sciences Fund II, L.P. | 4,783,102 5.800% | 4,783,102 (New Position) | Filing History |
| 2020-08-13 4:16 pm Purchase | 2020-08-11 | 13G | ARYA SCIENCES ACQUISITION CORP ARYA | Bain Capital Life Sciences Fund II, L.P. | 891,429 5.800% | 891,429 (New Position) | Filing History |
| 2020-07-20 4:16 pm Purchase | 2020-07-10 | 13G | Therapeutics Acquisition Corp. RACA | Bain Capital Life Sciences Fund II, L.P. | 891,429 6.300% | 891,429 (New Position) | Filing History |